2013
DOI: 10.1016/j.mjafi.2012.08.032
|View full text |Cite
|
Sign up to set email alerts
|

Systemic methotrexate: An effective alternative to surgery for management of unruptured ectopic pregnancy

Abstract: Methotrexate therapy is a safe and effective alternative for the management of unruptured ectopic pregnancies with minimal or no side-effects and associated advantage of avoiding invasive surgery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 9 publications
0
5
0
2
Order By: Relevance
“…today, advanced laboratory and imaging methods allow for early diagnosis and medical treatment with mtX in the cases with eP 8 . mtX is successfully used for the treatment of unruptured ePs as an effective, safe and noninvasive method with minimal or no side effects 9 . in the treatment of eP, mtX use has been reported to have no unfavorable effect on the subsequent ovarian reserve, ovarian responsiveness, or success of in vitro fertilization [10][11][12] .…”
Section: Discussionmentioning
confidence: 99%
“…today, advanced laboratory and imaging methods allow for early diagnosis and medical treatment with mtX in the cases with eP 8 . mtX is successfully used for the treatment of unruptured ePs as an effective, safe and noninvasive method with minimal or no side effects 9 . in the treatment of eP, mtX use has been reported to have no unfavorable effect on the subsequent ovarian reserve, ovarian responsiveness, or success of in vitro fertilization [10][11][12] .…”
Section: Discussionmentioning
confidence: 99%
“…This was probably because most of these patients were undergoing IVF and were on close follow up. 6 In another study by Vaswani, 54.6% patients had primary surgery and in the study by Bonin, 57.2% patients were treated with primary surgical therapy. 7,8 These figures are comparable to our study.…”
Section: Discussionmentioning
confidence: 94%
“…Найчастіше при лікуванні ПВ метотрексатом зустрічаються такі побічні ефекти, як стоматит, гастрит і ентеропатія (діарея), а також транзиторне підвищення рівня печінкових трансаміназ, що свідчить про ураження печінки. Так, при чотирикратному внутрішньом'язовому введенні метотрексату в дозі 1 мг/кг подібні ускладнення зареєстровані у 50% хворих [1,2,9].…”
Section: вступunclassified